Literature DB >> 16316960

Apolipoprotein B versus non-high-density lipoprotein cholesterol: and the winner is...

Allan D Sniderman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16316960     DOI: 10.1161/CIRCULATIONAHA.105.583336

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  15 in total

1.  Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort study.

Authors:  Samia Mora; Julie E Buring; Paul M Ridker; Yadong Cui
Journal:  Ann Intern Med       Date:  2011-12-06       Impact factor: 25.391

2.  Serum apolipoprotein B is inversely associated with eccentric left ventricular hypertrophy in peritoneal dialysis patients.

Authors:  Min Ye; Yanqiu Liu; Haoyu Wang; Na Tian; Wei Li; Wei He; Hong Lin; Rui Fan; Cuiling Li; Donghong Liu; Fengjuan Yao
Journal:  Int Urol Nephrol       Date:  2017-11-10       Impact factor: 2.370

3.  Identifying an Optimal Cutpoint for the Diagnosis of Hypertriglyceridemia in the Nonfasting State.

Authors:  Khendi T White; M V Moorthy; Akintunde O Akinkuolie; Olga Demler; Paul M Ridker; Nancy R Cook; Samia Mora
Journal:  Clin Chem       Date:  2015-06-12       Impact factor: 8.327

4.  Association of abnormal lipid spectrum with the disease activity of Takayasu arteritis.

Authors:  X Wang; B Chen; N Lv; Q Liu; Aimin Dang
Journal:  Clin Rheumatol       Date:  2014-11-12       Impact factor: 2.980

5.  Apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol. Predictive value for CHD severity and prognostic utility in CHD patients.

Authors:  P Liting; L Guoping; C Zhenyue
Journal:  Herz       Date:  2014-11-07       Impact factor: 1.443

6.  Reducing vascular events risk in patients with dyslipidaemia: an update for clinicians.

Authors:  Michel P Hermans; Jean-Charles Fruchart
Journal:  Ther Adv Chronic Dis       Date:  2011-09       Impact factor: 5.091

7.  Associations between intensive diabetes therapy and NMR-determined lipoprotein subclass profiles in type 1 diabetes.

Authors:  Ying Zhang; Alicia J Jenkins; Arpita Basu; Julie A Stoner; Maria F Lopes-Virella; Richard L Klein; Timothy J Lyons
Journal:  J Lipid Res       Date:  2015-12-09       Impact factor: 5.922

8.  Clinical impact of non-high density lipoprotein-cholesterol and apolipoprotein B on clinical outcomes in metabolic syndrome patients with acute myocardial infarction undergoing percutaneous coronary intervention.

Authors:  Khurshid Ahmed; Myung Ho Jeong; Rabin Chakraborty; Young Joon Hong; Mi Sook Oh; Kyung Hoon Cho; Min Chol Kim; Daisuke Hachinohe; Seung Hwan Hwang; Min Goo Lee; Doo Sun Sim; Keun Ho Park; Ju Han Kim; Youngkeun Ahn; Jung Chaee Kang
Journal:  Korean Circ J       Date:  2012-05-24       Impact factor: 3.243

Review 9.  Omega-3 polyunsaturated fatty acids: anti-inflammatory and anti-hypertriglyceridemia mechanisms in cardiovascular disease.

Authors:  Tewodros Shibabaw
Journal:  Mol Cell Biochem       Date:  2020-11-11       Impact factor: 3.396

10.  Discriminant ratio and biometrical equivalence of measured vs. calculated apolipoprotein B100 in patients with T2DM.

Authors:  Michel P Hermans; Sylvie A Ahn; Michel F Rousseau
Journal:  Cardiovasc Diabetol       Date:  2013-02-27       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.